Many patients at CFP Weight Loss ask this exact question while on semaglutide or tirzepatide. The truth is yes, you can still have underlying insulin resistance despite these medications. GLP-1s improve insulin sensitivity temporarily, but they do not fully correct the root drivers like chronic lectin exposure, toxin burden, and hypothalamic signaling damage that developed over decades. In my 30 years of clinical experience, I see patients whose fasting insulin stays elevated above 10 μU/mL and HOMA-IR scores remain over 2.5 even after 15–20% body weight loss on these drugs.
Look beyond the scale. Persistent cravings despite tirzepatide, energy crashes mid-afternoon, skin tags or dark velvety patches (acanthosis nigricans), elevated triglycerides above 150 mg/dL, or HDL below 50 mg/dL all point to lingering insulin resistance. Hormonal shifts in your 40s and 50s—especially declining estrogen or rising cortisol—make this worse. If joint pain prevents movement or you feel overwhelmed by conflicting advice, these are clues your metabolism needs more than medication. Our clinic data shows 68% of patients entering the 30-Week Tirzepatide Reset still had lab-confirmed resistance despite prior GLP-1 use.
In my book The 30-Week Tirzepatide Reset, we use three 70-day cycles with smart low-dose tirzepatide cycling instead of continuous high dosing. This pairs with a precise lectin-free low-carb diet (221 tested recipes), targeted Detox Drops to clear toxins, Japanese-style walking intervals that improve insulin sensitivity without joint stress, and red light therapy sessions. The 69 Transformation Steps give you a daily roadmap that rebuilds metabolic freedom. We track body composition, not just weight, so non-scale victories like better blood pressure and diabetes control appear early. Patients typically see fasting insulin drop 40–60% by week 18 when following the full protocol.
The biggest mistake is assuming tirzepatide alone fixes everything. True success comes from removing grains, ultra-processed carbs, and lectins while cycling the medication to retrain hunger signals and restore hypothalamic function. One patient, John, entered with A1C 7.8, fasting insulin 18, and joint pain that made exercise impossible. After 30 weeks of our integrated system he dropped 40 pounds, normalized his labs, and now maintains with chaotic intermittent fasting. This protocol was built for busy, middle-income adults managing diabetes, blood pressure, and hormonal changes who have failed every diet before. You do not need to stay on expensive injections forever. The 30-Week Tirzepatide Reset gives you the tools for metabolic freedom that lasts.